HomepageEarnings Events Newsdesk 2 hours ago Moderna, Inc (MRNA) European Medicines Agency’s Committee for Medicinal Products for Human Use Adopts Positive Opinion Recommending Marketing Authorization of mCOMBRIAX, Moderna’s mRNA Combination Vaccine Against Influenza and COVID-19 Moderna, Inc (NASDAQ: MRNA) FY 2026 Other Release Regeneron Pharmaceuticals Inc (REGN) Dupixent (dupilumab) Recommended for EU Approval to Treat Chronic Spontaneous Urticaria (CSU) in Young Children with Ongoing Symptoms Despite Treatment » « AECOM (ACM) AECOM to provide design, environmental, and project management services for Sound Transit’s Seattle-area regional transit expansion Newsdesk: